My Quote Request
No products added yet
6505-01-304-9761
20 Products
NDC24208-0505-05
LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505013049761
NSN
6505-01-304-9761
NDC24208-0505-05
LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505013049761
NSN
6505-01-304-9761
MFG
BAUSCH & LOMB PHARMACEUTICALS DIV BAUSCH & LOMB PHAMACEUTICAL
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V LEVOBUNOLOL HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION USP 5ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC SQUEEZE
SPECIAL FEATURES: W/QD (ONCE A DAY) COMPLIANCE CAP
Related Searches:
NDC11980-0252-65
LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505013049761
NSN
6505-01-304-9761
NDC11980-0252-65
LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505013049761
NSN
6505-01-304-9761
MFG
ALLERGAN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V LEVOBUNOLOL HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION USP 5ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC SQUEEZE
SPECIAL FEATURES: W/QD (ONCE A DAY) COMPLIANCE CAP
Related Searches:
CEFADYL
CEPHAPIRIN SODIUM,USP
NSN, MFG P/N
6505013050461
NSN
6505-01-305-0461
MFG
BRISTOL-MYERS SQUIBB PHARMACEUTICAL CO APOTHECON DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEPHAPIRIN EQUIVALENT
ADMINISTRATION: INTRAVENOUS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 100 ML. I.V. PIGGYBACK VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00015-7628-22
CEPHAPIRIN SODIUM,USP
NSN, MFG P/N
6505013050461
NSN
6505-01-305-0461
NDC00015-7628-22
CEPHAPIRIN SODIUM,USP
NSN, MFG P/N
6505013050461
NSN
6505-01-305-0461
MFG
BRISTOL-MYERS SQUIBB PHARMACEUTICAL CO APOTHECON DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEPHAPIRIN EQUIVALENT
ADMINISTRATION: INTRAVENOUS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 100 ML. I.V. PIGGYBACK VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC49452-4050-02
LIDOCAINE HYDROCHLORIDE,USP
NSN, MFG P/N
6505013051166
NSN
6505-01-305-1166
NDC49452-4050-02
LIDOCAINE HYDROCHLORIDE,USP
NSN, MFG P/N
6505013051166
NSN
6505-01-305-1166
MFG
SPECTRUM LABORATORY PRODUCTS INC. DBA SPECTRUM CHEMICALS AND LABORATORY PRODUCTS
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LIDOCAINE HYDROCHLORIDE USP POWDER FORM 100GM BT
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,SPECTRUM CHEMICAL
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC58406-0623-07
LEUCOVORIN CALCIUM FOR INJECTION
NSN, MFG P/N
6505013051167
NSN
6505-01-305-1167
NDC58406-0623-07
LEUCOVORIN CALCIUM FOR INJECTION
NSN, MFG P/N
6505013051167
NSN
6505-01-305-1167
MFG
AMGEN INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 350.000 MILLIGRAMS LEUCOVORIN EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEUCOVORIN CALCIUM FOR INJECTION 350MG VIAL
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 350.000 MILLIGRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
F89E508
MAGNESIUM CITRATE ORAL SOLUTION,USP
NSN, MFG P/N
6505013051170
NSN
6505-01-305-1170
F89E508
MAGNESIUM CITRATE ORAL SOLUTION,USP
NSN, MFG P/N
6505013051170
NSN
6505-01-305-1170
MFG
AIR FORCE MEDICAL LOGISTICS OFFICE
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MAGNESIUM CITRATE ORAL SOLUTION USP 10FL OZ BT 12S
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,HUMCO/WALMEAD
PRIMARY CONTAINER CONTENT QUANTITY: 300.000 MILLILITERS OR 10.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00395-0600-10
MAGNESIUM CITRATE ORAL SOLUTION,USP
NSN, MFG P/N
6505013051170
NSN
6505-01-305-1170
NDC00395-0600-10
MAGNESIUM CITRATE ORAL SOLUTION,USP
NSN, MFG P/N
6505013051170
NSN
6505-01-305-1170
MFG
AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MAGNESIUM CITRATE ORAL SOLUTION USP 10FL OZ BT 12S
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,HUMCO/WALMEAD
PRIMARY CONTAINER CONTENT QUANTITY: 300.000 MILLILITERS OR 10.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00869-0693-38
MAGNESIUM CITRATE ORAL SOLUTION,USP
NSN, MFG P/N
6505013051170
NSN
6505-01-305-1170
NDC00869-0693-38
MAGNESIUM CITRATE ORAL SOLUTION,USP
NSN, MFG P/N
6505013051170
NSN
6505-01-305-1170
MFG
AARON LABS
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MAGNESIUM CITRATE ORAL SOLUTION USP 10FL OZ BT 12S
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,HUMCO/WALMEAD
PRIMARY CONTAINER CONTENT QUANTITY: 300.000 MILLILITERS OR 10.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC87701-0402-44
MAGNESIUM CITRATE ORAL SOLUTION,USP
NSN, MFG P/N
6505013051170
NSN
6505-01-305-1170
NDC87701-0402-44
MAGNESIUM CITRATE ORAL SOLUTION,USP
NSN, MFG P/N
6505013051170
NSN
6505-01-305-1170
MFG
AARON INDUSTRIES INC DBA BUILDERS LUMBER AND SUPPLY
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MAGNESIUM CITRATE ORAL SOLUTION USP 10FL OZ BT 12S
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,HUMCO/WALMEAD
PRIMARY CONTAINER CONTENT QUANTITY: 300.000 MILLILITERS OR 10.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
0332-56
ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP
NSN, MFG P/N
6505013053136
NSN
6505-01-305-3136
0332-56
ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP
NSN, MFG P/N
6505013053136
NSN
6505-01-305-3136
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 225.000 MILLIGRAMS ALUMINUM HYDROXIDE PER 5 MILLILITERS AND 200.000 MILLIGRAMS MAGNESIUM HYDROXIDE PER 5 MILLILITERS AND 25.000 MILLIGRAMS SIMETHICONE PER 5 MILLILITERS
ADMINISTRATION: ORAL
FEATURES PROVIDED: UNIT DOSE
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SODIUM-FREE
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
MAALOX PLUS SUSP
ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP
NSN, MFG P/N
6505013053136
NSN
6505-01-305-3136
MAALOX PLUS SUSP
ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP
NSN, MFG P/N
6505013053136
NSN
6505-01-305-3136
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 225.000 MILLIGRAMS ALUMINUM HYDROXIDE PER 5 MILLILITERS AND 200.000 MILLIGRAMS MAGNESIUM HYDROXIDE PER 5 MILLILITERS AND 25.000 MILLIGRAMS SIMETHICONE PER 5 MILLILITERS
ADMINISTRATION: ORAL
FEATURES PROVIDED: UNIT DOSE
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SODIUM-FREE
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
NDC00067-0332-22
ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP
NSN, MFG P/N
6505013053136
NSN
6505-01-305-3136
NDC00067-0332-22
ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP
NSN, MFG P/N
6505013053136
NSN
6505-01-305-3136
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 225.000 MILLIGRAMS ALUMINUM HYDROXIDE PER 5 MILLILITERS AND 200.000 MILLIGRAMS MAGNESIUM HYDROXIDE PER 5 MILLILITERS AND 25.000 MILLIGRAMS SIMETHICONE PER 5 MILLILITERS
ADMINISTRATION: ORAL
FEATURES PROVIDED: UNIT DOSE
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SODIUM-FREE
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
NDC00054-4657-25
OXYCODONE HYDROCHLO
NSN, MFG P/N
6505013053145
NSN
6505-01-305-3145
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 5 MG.; 100 TABLETS PER BOTTLE
Related Searches:
ROXICODONE
OXYCODONE HYDROCHLO
NSN, MFG P/N
6505013053145
NSN
6505-01-305-3145
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 5 MG.; 100 TABLETS PER BOTTLE
Related Searches:
NDC00078-0078-05
NORTRIPTYLINE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505013054523
NSN
6505-01-305-4523
NDC00078-0078-05
NORTRIPTYLINE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505013054523
NSN
6505-01-305-4523
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NORTRIPTYLINE HYDROCHLORIDE CAPSULES USP 50MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 50.000 MG NORTRIPTYLINE EQUIVALENT
THERAPEUTIC EQUIVALENT: PAMELOR BY SANDOZ PHARMACEUTICALS
Related Searches:
PAMELOR
NORTRIPTYLINE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505013054523
NSN
6505-01-305-4523
PAMELOR
NORTRIPTYLINE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505013054523
NSN
6505-01-305-4523
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NORTRIPTYLINE HYDROCHLORIDE CAPSULES USP 50MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 50.000 MG NORTRIPTYLINE EQUIVALENT
THERAPEUTIC EQUIVALENT: PAMELOR BY SANDOZ PHARMACEUTICALS
Related Searches:
NDC00026-0601-30
ALPHA-1-PROTEINASE INHIBITOR,HUMAN,STERILE
NSN, MFG P/N
6505013054683
NSN
6505-01-305-4683
NDC00026-0601-30
ALPHA-1-PROTEINASE INHIBITOR,HUMAN,STERILE
NSN, MFG P/N
6505013054683
NSN
6505-01-305-4683
MFG
TALECRIS BIOTHERAPEUTICS INC.
Description
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALPHA-1-PROTEINASE INHIBITOR HUMAN STERILE 500MG VIAL PG
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLIGRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: PRESERVATIVE-FREE; WITH 20 ML VIAL STERILE WATER FOR INJECTION,USP,STERILE DOUBLE-ENDED TRANSFER NEEDLE,AND STERILE FILTER NEEDLE
Related Searches:
NDC00006-3508-04
ENALAPRILAT INJECTION
NSN, MFG P/N
6505013056988
NSN
6505-01-305-6988
NDC00006-3508-04
ENALAPRILAT INJECTION
NSN, MFG P/N
6505013056988
NSN
6505-01-305-6988
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.250 MILLIGRAMS ENALAPRILAT,ANHYDROUS PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ENALAPRILAT INJECTION 1.25MG ANHYDROUS ENALAPRILAT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1.250 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
NDC00074-2122-02
ENALAPRILAT INJECTION
NSN, MFG P/N
6505013056988
NSN
6505-01-305-6988
NDC00074-2122-02
ENALAPRILAT INJECTION
NSN, MFG P/N
6505013056988
NSN
6505-01-305-6988
MFG
ABBOTT LABORATORIES INC ROSS PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.250 MILLIGRAMS ENALAPRILAT,ANHYDROUS PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ENALAPRILAT INJECTION 1.25MG ANHYDROUS ENALAPRILAT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1.250 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
